Pharmacokinetics of isoniazid and rifampin in adults with tuberculosis.

被引：0
|
作者：
Auclair, B
Burman, WJ
Stambaugh, JJ
Berning, SE
Ashkin, D
Peloquin, CA
机构：
[1] Natl Jewish, Denver, CO USA
[2] Denver Publ Hlth, Denver, CO USA
[3] AG Holley Hosp, Lantana, FL USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 1999年 / 159卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A495 / A495
页数：1
相关论文
共 50 条
  • [41] Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis
    Gurumurthy, P
    Ramachandran, G
    Kumar, AKH
    Rajasekaran, S
    Padmapriyadarsini, C
    Swaminathan, S
    Venkatesan, P
    Sekar, L
    Kumar, S
    Krishnarajasekhar, OR
    Paramesh, P
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (02) : 280 - 283
  • [42] Pyrosequencing for Rapid Detection of Mycobacterium tuberculosis Resistance to Rifampin, Isoniazid, and Fluoroquinolones
    Bravo, Lulette Tricia C.
    Tuohy, Marion J.
    Ang, Concepcion
    Destura, Raul V.
    Mendoza, Myrna
    Procop, Gary W.
    Gordon, Steven M.
    Hall, Geraldine S.
    Shrestha, Nabin K.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (12) : 3985 - 3990
  • [43] PREDISPOSING FACTORS IN HEPATITIS INDUCED BY ISONIAZID-RIFAMPIN TREATMENT OF TUBERCULOSIS
    GRONHAGENRISKA, C
    HELLSTROM, PE
    FROSETH, B
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1978, 118 (03): : 461 - 466
  • [44] Dose selection and pharmacokinetics of rifampin in elephants for the treatment of tuberculosis
    Peloquin, C. A.
    Maslow, J. N.
    Mikota, S. K.
    Forrest, A.
    Dunker, F.
    Isaza, R.
    Peddie, L. R.
    Peddie, J.
    Zhu, M.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2006, 29 (06) : 581 - 585
  • [45] Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment
    Bhatt, N. B.
    Barau, C.
    Amin, A.
    Baudin, E.
    Meggi, B.
    Silva, C.
    Furlan, V.
    Grinsztejn, B.
    Barrail-Tran, A.
    Bonnet, M.
    Taburet, A. M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (06) : 3182 - 3190
  • [46] Short-course isoniazid and rifampin compared with isoniazid for latent tuberculosis infection:: A randomized clinical trial
    Paloma Geijo, Maria
    Rosa Herranz, Carmen
    Vano, David
    Jesus Garcia, Angel
    Garcia, Montserrat
    Francisco Dimas, Jose
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2007, 25 (05): : 300 - 304
  • [47] ISONIAZID, RIFAMPIN, AND HEPATOTOXICITY
    GANGADHARAM, PRJ
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 133 (06): : 963 - 965
  • [48] Pharmacokinetics of isoniazid in Indian children with tuberculosis on daily treatment
    Shah, I.
    Jadhao, N.
    Mali, N.
    Deshpande, S.
    Gogtay, N.
    Thatte, U.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (01) : 52 - 57
  • [49] Clinical experience with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis
    Horn, DL
    Hewlett, D
    Alfalla, C
    Patel, A
    Brudney, K
    Crawford, JT
    Alland, D
    Kreiswirth, B
    Opal, SM
    Peterson, S
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1996, 5 (01) : 68 - 72
  • [50] ISONIAZID-RESISTANT TUBERCULOSIS - A COMMUNITY OUTBREAK AND REPORT OF A RIFAMPIN PROPHYLAXIS FAILURE
    LIVENGOOD, JR
    SIGLER, TG
    FOSTER, LR
    BOBST, JG
    SNIDER, DE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (19): : 2847 - 2849
12345